These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4430845)

  • 41. Approved names.
    Lancet; 1970 Jan; 1(7640):228. PubMed ID: 4189016
    [No Abstract]   [Full Text] [Related]  

  • 42. Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint.
    Bansinath M; Sequeira RP; Shukla VK; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):279-83. PubMed ID: 6746151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Product dissolution methods.
    Leeson LJ
    J Pharm Sci; 1973 Apr; 62(4):IV. PubMed ID: 4699003
    [No Abstract]   [Full Text] [Related]  

  • 44. Similar drug names a risky prescription.
    Hampton T
    JAMA; 2004 Apr; 291(16):1948-9. PubMed ID: 15113794
    [No Abstract]   [Full Text] [Related]  

  • 45. Industry views of biosimilar development in Japan.
    Horikawa H; Tsubouchi M; Kawakami K
    Health Policy; 2009 Jul; 91(2):189-94. PubMed ID: 19157628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The trade-mark].
    Kohlstaedt E
    Med Welt; 1969 Oct; 40():2209-11. PubMed ID: 5355668
    [No Abstract]   [Full Text] [Related]  

  • 47. AFP policy on using generic and brand names for drugs.
    McCauley J
    Am Fam Physician; 2004 Sep; 70(6):1031-2; discussion 1032. PubMed ID: 15456112
    [No Abstract]   [Full Text] [Related]  

  • 48. Naming a new drug: mythology, Greek etymology, and anagrams play a part.
    J Med Soc N J; 1972 Jan; 69(1):14. PubMed ID: 4500441
    [No Abstract]   [Full Text] [Related]  

  • 49. The naming of drugs.
    Aronson SM
    R I Med; 1993 Aug; 76(8):378-9. PubMed ID: 8219378
    [No Abstract]   [Full Text] [Related]  

  • 50. Names for hi-jacking.
    Nature; 1995 Feb; 373(6513):370. PubMed ID: 7830775
    [No Abstract]   [Full Text] [Related]  

  • 51. Names in vain.
    Vazquez E; Whitfield L
    Posit Aware; 1997; 8(6):13. PubMed ID: 11364853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reference pricing of pharmaceuticals.
    Brekke KR; Königbauer I; Straume OR
    J Health Econ; 2007 May; 26(3):613-42. PubMed ID: 17188769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medicine in Mexico--III drugs.
    Daschbach CC; Connolly RJ
    Ariz Med; 1977 Sep; 34(9):636-7. PubMed ID: 907502
    [No Abstract]   [Full Text] [Related]  

  • 54. THE GENERIC DRUG DISPUTE IN LOUISIANA.
    ULRICH CA
    J La State Med Soc; 1965 May; 117():141-51. PubMed ID: 14288401
    [No Abstract]   [Full Text] [Related]  

  • 55. NEW and nonofficial remedies: new generic and brand names recognized by the Council.
    J Am Med Assoc; 1954 Feb; 154(9):764-5. PubMed ID: 13129036
    [No Abstract]   [Full Text] [Related]  

  • 56. International non-proprietary names for pharmaceutical preparations.
    WHO Chron; 1965 Nov; 19(11):446-60. PubMed ID: 5837383
    [No Abstract]   [Full Text] [Related]  

  • 57. International non-proprietary names for pharmaceutical preparations.
    WHO Chron; 1967 Feb; 21(2):70-9. PubMed ID: 6044819
    [No Abstract]   [Full Text] [Related]  

  • 58. International non-proprietary names for pharmaceutical preparations.
    WHO Chron; 1966 Jun; 20(6):216-28. PubMed ID: 5940179
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug names and the USAN.
    Cutting WC
    Hawaii Med J; 1968; 27(4):324-6. PubMed ID: 5644837
    [No Abstract]   [Full Text] [Related]  

  • 60. Trade names in publications.
    Micheli F
    Mov Disord; 2007 Jan; 22(1):149-50. PubMed ID: 17080445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.